FDA
approval
· 2020-08-18
FDA Approved: RANOLAZINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
FDA approved Lupin Pharmaceuticals' supplemental application for ranolazine, enabling a generic version of the heart medicine to be marketed. This is a suppleme…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RANOLAZINE (RANOLAZINE)